methylphenidate has been researched along with DiGeorge Syndrome in 3 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
DiGeorge Syndrome: Congenital syndrome characterized by a wide spectrum of characteristics including the absence of the THYMUS and PARATHYROID GLANDS resulting in T-cell immunodeficiency, HYPOCALCEMIA, defects in the outflow tract of the heart, and craniofacial anomalies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "013), and similar side effect rates." | 1.72 | Stimulant treatment effectiveness, safety and risk for psychosis in individuals with 22q11.2 deletion syndrome. ( Basel, D; Eliez, S; Gothelf, D; Maeder, J; Mosheva, M; Schneider, M; Shani, S; Weinberger, R, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Basel, D | 1 |
| Mosheva, M | 1 |
| Maeder, J | 2 |
| Schneider, M | 2 |
| Shani, S | 1 |
| Weinberger, R | 2 |
| Eliez, S | 2 |
| Gothelf, D | 2 |
| Mancini, V | 1 |
| Sandini, C | 1 |
| Journal, F | 1 |
| Kliegel, M | 1 |
| Green, T | 1 |
| Diamond, A | 1 |
| Berant, M | 1 |
| Hirschfeld, L | 1 |
| Frisch, A | 1 |
| Zarchi, O | 1 |
| Weizman, A | 1 |
2 trials available for methylphenidate and DiGeorge Syndrome
| Article | Year |
|---|---|
Selective Effects of Methylphenidate on Attention and Inhibition in 22q11.2 Deletion Syndrome: Results From a Clinical Trial.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; DiGe | 2022 |
The effect of methylphenidate on prefrontal cognitive functioning, inattention, and hyperactivity in velocardiofacial syndrome.
Topics: Adolescent; Attention; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Catechol O-Met | 2011 |
1 other study available for methylphenidate and DiGeorge Syndrome
| Article | Year |
|---|---|
Stimulant treatment effectiveness, safety and risk for psychosis in individuals with 22q11.2 deletion syndrome.
Topics: Adolescent; Catechol O-Methyltransferase; Central Nervous System Stimulants; DiGeorge Syndrome; Huma | 2022 |